|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In-situ cosmogenic ^(36)Cl denudation rates of carbonates in Guizhou karst area显示文摘This study quantifies surface denudation of carbonate rocks by the first application of in-situ cosmogenic36Cl in China. Concentrations of natural Cl and in-situ cosmogenic36Cl in bare carbonates from Guizhou karst areas were measured with isotope dilution by accelerator mass spectrometer. The Cl concentration varied from 16 to 206 ppm. The 36Cl concentrations were in range of (0.8-2.4)106 atom g-1 , resulting in total denudation rates of 20-50 mm ka-1 that averaged over a 104-105 a timescale. The 36Cl-denudation rates showed roughly a negative correlation with the local mean temperature. This preliminary observation may suggest the variations of proportions of chemical weathering and physical erosion in denudation process, depending upon local climatic conditions. | XU Sheng LIU CongQiang FREEMAN Stewart LANG YunChao SCHNABEL Christoph TU ChengLong WILCKEN Klaus ZHAO ZhiQi | 2013 | Chinese Science Bulletin2013，58，20： | 7 |
| 2 | 冠心病患者载脂蛋白AI基因多态性的研究显示文摘目的 探讨载脂蛋白 AI (Apo AI)基因多态性与冠心病的关系。方法 经冠状动脉造影选择对照组(1 82例 )和冠心病组 (4 62例 ) ,应用 PCR,Msp I内切酶消化及 PAGE的方法确定 Apo AI基因多态性。结果 冠心病组和对照组均以 M1 + + 、M2 + + 基因型最常见 ,M1 + - 次之 ,两组比较均无显著性差异 (P>0 .0 5 )。冠心病组 M1 - - 、M2 + -基因型频率明显高于对照组 ,并且随着病变冠脉的数量增加而增加 (P<0 .0 2 5~ 0 .0 0 5 )。各冠心病亚组中 ,两种 Apo AI基因多态性并存的频率高于对照组 ,3支病变组与对照组、 1支病变组比较 ,差异有显著性 (P<0 .0 5~ 0 .0 2 5 )。结论 Apo | 刘生祥 Danid Wilcken 杨金娟 | 2001 | 心脑血管病防治2001，1，2： | 2 |
| 3 | The pathogenesis of coronary disease.A possible role for methionine metabolism显示文摘 | Wilcken DE Wilcken B | | 0，，： | 2 |
| 4 | 贵州喀斯特地区碳酸盐岩的宇宙成因核素^(36)Cl侵蚀速率显示文摘喀斯特地区侵蚀速率是理解全球碳循环、喀斯特地貌演化以及土地利用等学科的最基本问题之一.侵蚀速率估算方法主要包括:(1)流域河水化学溶解物平衡的计算;(2)置于不同环境下的大理岩片重量损失的观测;(3)显微侵蚀测量仪对暴露地表的直接测量;(4)碳酸盐岩中石英脉的长期观测;(5)地表岩石中宇宙成因核素36Cl(半衰期3万年)的测定.与其他方法相比,地表岩石中36Cl含量反映了104-105年尺度内的岩石暴露和侵蚀历史. | 徐胜 刘丛强 FREEMAN Stewart 郎赟超 SCHNABEL Christoph 涂成龙 WILCKEN Klaus 赵志琦 | 2013 | 科学通报2013，58，19： | 2 |
| 5 | Documentation of acute compartment syndrome at an academic health-care center 显示文摘 | Cascio BM Wilckens JH Ain MC | 2005 | J Bone Joint Surg Am2005，87，2： | 1 |
| 6 | Clinical approach to inborn errors of metagolism presenting in the newborn period显示文摘 | Ellaway CJ Wilcken B Christodoulou J | 2002 | J Paediatr Child Health2002，38，5： | 1 |
| 7 | Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase(MTHFR) C677T Mutation 显示文摘 | Wilcken DEL Wang XL Sim AS | 1996 | Arterioscler Thromb Vasc Biol1996，16，： | 1 |
| 8 | The natural history of vascular disease in homocystinuria and the effects of treatment显示文摘 | WILCKEN D E WILCKEN B | 1997 | J Inherit Metab Dis1997，20，2： | 1 |
| 9 | Tow-yearpilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia显示文摘 | Gleen HK Wiley V Wilcken B | 2008 | J Paediatr Child Health2008，44，10： | 1 |
| 10 | Age-related decline in controlled retrieval:The role of the PFC and sleep 显示文摘 | Wilckens K A Erickson K I Wheeler M E | 2012 | Neural Plast2012，2012，62： | 1 |
| 11 | Single agent versus combina- tion chemotherapy for metastatic breast cancer 显示文摘 | Carrick S Parker S Wilcken N | 2009 | Cochrane Data- base Syst Rev2009，15，00： | 1 |
| 12 | Chemotherapy alone versus endo- crine therapy alone for metastatic breast cancer显示文摘 | Wilcken N Hombuckle J Ghersi D | 2003 | Coehrane Database Syst Rev2003，，00： | 1 |
| 13 | The Glu298Asp (894G/T)mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease显示文摘 | Cai H Wilcken D E Wang X L | 1999 | J Mol Med1999，77，6： | 1 |
| 14 | Homocysteine and cardiovascular disease: cause or effect ? 显示文摘 | Brattstrom L Wilcken DE | 2000 | Am J Clin Nutr2000，72，2： | 1 |
| 15 | Chemotherapy alone versusendocrine therapy alone for metastatic breast cancer显示文摘 | Wilcken N Hombuckle J Ghersi D | 2003 | CochraneDatabase Syst Rev2003，，00： | 1 |
| 16 | Homocysteine and cadiovascular disease,cause or effect显示文摘 | Brattstom L Wilcken DEL | 2000 | Am J Clin Nutr2000，72，2： | 1 |
| 17 | Novel Risk Factors for Vascular Disease:the Homocysteine Hypothesis of Cardiovascular Disease显示文摘 | Wilcken D E | 1998 | J Cardiovasc Risk1998，5，： | 1 |
| 18 | Endocrine therapy for desmoid t- umors显示文摘 | Wilcken N Tattersall M H | 1991 | Cancer1991，68，6： | 1 |
| 19 | Vascular complications of severe hyperhomocyste-inemia in patient with homocystinuria duo to CBS deficiency显示文摘 | Yap S Eileen R Wilcken B | 2000 | Semin Thromb Haemost2000，26，： | 1 |
| 20 | Screening newboms for inborn errors of metabolism by tandem mass spectrometry显示文摘 | Wilcken B Wiley V Hammond J | 2003 | N Engl J Med2003，348，23： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员